The global peripheral vascular devices market is expected to reach a valuation of USD 4.7 billion by the end of 2022 and further expand at a CAGR of 6.6% to reach a valuation of USD 8.9 billion by 2032. According to a recent study by Future Market Insights, peripheral vascular stents are leading the market, accounting for approximately 78.5% of the global market share in 2021.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2021 | USD 4.5 Billion |
| Market Value 2022 | USD 4.7 Billion |
| Market Value 2032 | USD 8.9 Billion |
| CAGR 2022 to 2032 | 6.6% |
| Market Share of Top 5 Countries | 57.6% |
| Key Market Players | Abbott Laboratories; Boston Scientific Corporation; Cook Medical Inc.; MicroPort Scientific Corporation (Endovastec™); Medtronic Plc.; Cardinal Health, Inc.; B. Braun Melsungen AG; BIOTRONIK SE & Co. KG; Becton, Dickinson, and Company; W. L. Gore & Associates Inc.; Getinge AB; Terumo Corp; Kyoto Medical Planning Co Ltd; iVascular S.L.U; AMG International GmbH; ENDOCOR GmbH; Meril Life Sciences Pvt. Ltd.; Nano Therapeutics Pvt Ltd; Koninklijke Philips N.V.; REVA Medical |
Plaque in the arteries that carry blood to the body is the primary cause of peripheral arterial disease (PAD). It generally suggests systemic atherosclerosis and an elevated risk of cardiovascular events. Diabetic patients, smokers, the elderly, and those with cardiovascular disease are most vulnerable to PAD.
About half of the persons with PAD are asymptomatic, regardless of whether it causes symptoms, PAD can imply systemic atherosclerosis and an elevated risk of heart disease and stroke. Many novel technologies, as well as new versions of existing devices, are now available for endovascular, less invasive treatment of PAD.
The market value for peripheral vascular devices was approximately 52.0% of the overall USD 8.6 Billion of the global stents market in 2021. The sales of peripheral vascular devices expanded at a CAGR of 4.4% from 2012 to 2021, owing to a high incidence of cardiovascular disease burden, globally.
Minimally invasive endovascular procedures to expand the artery opening, such as angioplasty or atherectomy, are currently employed more frequently than bypass surgery as the initial treatment strategy for PAD. The two primary forms of endovascular therapies for PAD are balloon angioplasty with stenting and atherectomy. Endovascular therapy or vascular surgery can be used to treat patients with severe PAD.
A large volume of the population worldwide suffers from critical limb ischemia (CLI), the most severe form of peripheral arterial disease (PAD). While endovascular therapy has been the first choice of treatment in the majority of cases, there is still a range of barriers to the best treatment of diseases such as infrapopliteal (IP) disease.
Endovascular therapy outcomes have significantly improved as technology has advanced. Several innovative technologies are now being developed, including intravascular lithotripsy, percutaneous femoropopliteal bypass, paclitaxel-eluting stents, and the adventitial delivery of anti-restenosis medicines.
As the world's population has grown, so has the demand for healthcare services. Due to an increase in the senior population, the number of individuals suffering from cardiovascular disorders has continually increased. As a result, the demand for devices used in the treatment of cardiovascular disorders has increased. Peripheral vascular devices can be used to treat a variety of heart and arterial problems.
Additionally, technological developments have had a favorable impact on the market shares for peripheral vascular devices. Moreover, the rapid growth of the healthcare industry in developing nations has a beneficial impact on the peripheral vascular devices market growth.
Thus, owing to the aforementioned factors, the global peripheral vascular devices market is expected to grow at a CAGR of 6.6% during the forecast period from 2022 to 2032.
The market for peripheral vascular devices is set to be presented with opportunistic growth over the forecast period. This growth is expected to be owed to the introduction of novel products, such as upgraded drug-eluting vascular stents.
The FDA granted Boston Scientific an investigational device exemption (IDE) in 2015 to initiate a global, pivotal study of the Eluvia drug-eluting stent. EluviaTM Drug-Eluting Vascular Stent System was designed exclusively for the treatment of peripheral artery disease, and in 2018, the USA Food and Drug Administration (FDA) authorized its Premarket Approval (PMA) application.
Stents were first created as a tube that could be inserted intraluminally out of a metal alloy. Bare metal stents (BMSs), coated stents, and drug-eluting stents (DESs) are all types of stents that have evolved in recent years. They may also be self-expanding and balloon expandable. Stents are currently mostly made of nickel and titanium, stainless steel, cobalt chromium, or nickel and titanium.
Biodegradable polymers have been used to create bioabsorbable stents. Although the concept of a bioabsorbable material holds promise, it has not been established in randomized controlled studies and has not demonstrated enhanced or equivalent patency when compared to endarterectomy and PTA.
With the research and development required to improve the outcomes over more standardized approaches, the key players are presented with lucrative prospects for advancement.
The growth of the peripheral vascular devices market is restricted by factors that include device recall activities, device limitations, and the high cost of advanced devices. Medtronic issued the FDA’s most serious type of medical device recall, Class I, in response to reports of injuries associated with its HawkOne system for clearing blocked arteries.
About 95,000 devices sold to the United States of America since 2018 were subject to the recall, which Medtronic announced in early December 2021. Moreover, the material cost composition of peripheral vascular devices is greater within institutional settings, and the high-cost burden of adoption of these devices is a factor, which hinders the overall market.
Additionally, device limitations during the surgical procedure further pose a restrictive impact on the market expansion. Several procedures utilizing drug-eluting balloons come with the risk of occurrence of restenosis after treatment.
Keeping the above factors into consideration, the global market for peripheral vascular stents is subject to repression, in terms of growth, over the forecast period.
The USA dominates the North American region with a total market share of about 94.5% in 2021 and is expected to continue to experience the same growth throughout the forecast period. With a large population suffering from cardiovascular disorders, the product adoption rate for peripheral vascular devices is quite high within the country, thus propelling the USA into being the largest contributor towards the growth of the global peripheral vascular stents market.
China holds approximately 56.5% share of the East Asia market in 2021 and is projected to display growth at a lucrative CAGR of 8.5% during the forecast period. China presents lucrative prospects for the growth of the overall market, owing to a prospective, multicenter, randomized, and controlled, superiority trial done at 14 hospitals in China as part of the FREEWAY-CHINA project.
The objective of this study was to assess the effectiveness and safety of the FREEWAY paclitaxel-coated balloon. According to the study, the FREEWAY paclitaxel-coated balloon outperformed the uncoated balloon in Chinese patients' target lesion revascularization at the 6- and 12-month mark. With established device adaptability and efficacy in the demographic, the market is poised to be fuelled by future product adoption within the country.
Germany is set to exhibit a CAGR of nearly 6.0% in the European peripheral vascular devices market during the forecast period. The market expansion in Germany is owed to the large geriatric population, advanced medical device technology and research, and a high prevalence of chronic diseases.
Peripheral vascular stents are expected to present high growth at a CAGR of 6.0% by the end of the forecast period. With angioplasty procedures, the use of peripheral vascular stents is adapted for implantation into the artery for the removal of calcified lesions. A large disease population globally calls for a greater number of procedures involving the adoption of peripheral vascular stents, thus promoting this segment’s overall market value.
Peripheral arterial disease holds a revenue share of 30.3% in the global market in 2021. Growing urban lifestyle, as well as a large population consuming alcohol and tobacco, are factors propelling the development of peripheral arterial disease. This segment thus holds a major focus within the market.
iliac artery holds a global revenue share of around 48.1% in 2021. Claudication and/or critical limb ischemia are primarily caused by aortoiliac disease, which has a prevalence of up to 10% in the general population and up to 20% in people over the age of 70 (Annals of Vascular Surgery, 2017). Peripheral artery disease includes aortoiliac occlusive disease.
A substantial portion of the global market for peripheral vascular devices is focused on the iliac artery segment due to increased concerns about this condition.
Hospitals hold the highest market share of about 60.4% during the year 2021. The growing prevalence of chronic and infectious diseases, as well as the associated increasing volumes of surgical procedures, have driven this segment to be a dominant fragment, propelling sales of the overall peripheral vascular devices market.
The overall market is highly fragmented, with multiple rivals in the peripheral vascular device production sphere. These companies are using techniques such as mergers and acquisitions, partnerships and collaborations, and new product releases to meet consumer demand and expand their customer base.
Similarly, recent developments related to companies manufacturing peripheral vascular devices, have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2012 to 2021 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Nordic countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, Israel, North Africa, and South Africa |
| Key Market Segments Covered | Product, Indication, Artery, End User, and Region |
| Key Companies Profiled | Abbott Laboratories; Boston Scientific Corporation; Cook Medical Inc.; MicroPort Scientific Corporation (Endovastec™); Medtronic Plc.; Cardinal Health, Inc.; B. Braun Melsungen AG; BIOTRONIK SE & Co. KG; Becton, Dickinson, and Company; W. L. Gore & Associates Inc.; Getinge AB; Terumo Corp; Kyoto Medical Planning Co Ltd; iVascular S.L.U; AMG International GmbH; ENDOCOR GmbH; Meril Life Sciences Pvt. Ltd.; Nano Therapeutics Pvt Ltd; Koninklijke Philips N.V.; REVA Medical |
| Pricing | Available upon Request |
Table 01: Global Market Size (US$ Million) Analysis 2012 to 2021, By Product
Table 02: Global Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 03: Global Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 04: Global Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 05: Global Market Size (US$ Million) Analysis 2012 to 2021, By Indication
Table 06: Global Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Indication
Table 07: Global Market Size (US$ Million) Analysis 2012 to 2021, By Artery
Table 08: Global Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Artery
Table 09: Global Market Size (US$ Million) Analysis 2012 to 2021, By End User
Table 10: Global Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 11: Global Market Size (US$ Million) Analysis 2012 to 2021, By Region
Table 12: Global Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Region
Table 13: Global Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Region
Table 14: Global Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Region
Table 15: North America Market Size (US$ Million) Analysis 2012 to 2021, By Product
Table 16: North America Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 17: North America Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 18: North America Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 19: North America Market Size (US$ Million) Analysis 2012 to 2021, By Indication
Table 20: North America Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Indication
Table 21: North America Market Size (US$ Million) Analysis 2012 to 2021, By Artery
Table 22: North America Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Artery
Table 23: North America Market Size (US$ Million) Analysis 2012 to 2021, By End User
Table 24: North America Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 25: North America Market Size (US$ Million) Analysis 2012 to 2021, By Country
Table 26: North America Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 27: Latin America Market Size (US$ Million) Analysis 2012 to 2021, By Product
Table 28: Latin America Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 29: Latin America Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 30: Latin America Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 31: Latin America Market Size (US$ Million) Analysis 2012 to 2021, By Indication
Table 32: Latin America Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Indication
Table 33: Latin America Market Size (US$ Million) Analysis 2012 to 2021, By Artery
Table 34: Latin America Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Artery
Table 35: Latin America Market Size (US$ Million) Analysis 2012 to 2021, By End User
Table 36: Latin America Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 37: Latin America Market Size (US$ Million) Analysis 2012 to 2021, By Country
Table 38: Latin America Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 39: Europe Market Size (US$ Million) Analysis 2012 to 2021, By Product
Table 40: Europe Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 41: Europe Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 42: Europe Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 43: Europe Market Size (US$ Million) Analysis 2012 to 2021, By Indication
Table 44: Europe Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Indication
Table 45: Europe Market Size (US$ Million) Analysis 2012 to 2021, By Artery
Table 46: Europe Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Artery
Table 47: Europe Market Size (US$ Million) Analysis 2012 to 2021, By End User
Table 48: Europe Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 49: Europe Market Size (US$ Million) Analysis 2012 to 2021, By Country
Table 50: Europe Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 51: East Asia Market Size (US$ Million) Analysis 2012 to 2021, By Product
Table 52: East Asia Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 53: East Asia Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 54: East Asia Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 55: East Asia Market Size (US$ Million) Analysis 2012 to 2021, By Indication
Table 56: East Asia Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Indication
Table 57: East Asia Market Size (US$ Million) Analysis 2012 to 2021, By Artery
Table 58: East Asia Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Artery
Table 59: East Asia Market Size (US$ Million) Analysis 2012 to 2021, By End User
Table 60: East Asia Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 61: East Asia Market Size (US$ Million) Analysis 2012 to 2021, By Country
Table 62: East Asia Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 63: South Asia Market Size (US$ Million) Analysis 2012 to 2021, By Product
Table 64: South Asia Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 65: South Asia Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 66: South Asia Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 67: South Asia Market Size (US$ Million) Analysis 2012 to 2021, By Indication
Table 68: South Asia Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Indication
Table 69: South Asia Market Size (US$ Million) Analysis 2012 to 2021, By Artery
Table 70: South Asia Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Artery
Table 71: South Asia Market Size (US$ Million) Analysis 2012 to 2021, By End User
Table 72: South Asia Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 73: South Asia Market Size (US$ Million) Analysis 2012 to 2021, By Country
Table 74: South Asia Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 75: Oceania Market Size (US$ Million) Analysis 2012 to 2021, By Product
Table 76: Oceania Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 77: Oceania Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 78: Oceania Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 79: Oceania Market Size (US$ Million) Analysis 2012 to 2021, By Indication
Table 80: Oceania Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Indication
Table 81: Oceania Market Size (US$ Million) Analysis 2012 to 2021, By Artery
Table 82: Oceania Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Artery
Table 83: Oceania Market Size (US$ Million) Analysis 2012 to 2021, By End User
Table 84: Oceania Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 85: Oceania Market Size (US$ Million) Analysis 2012 to 2021, By Country
Table 86: Oceania Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Table 87: MEA Market Size (US$ Million) Analysis 2012 to 2021, By Product
Table 88: MEA Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Product
Table 89: MEA Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 90: MEA Market Volume (in Thousands) Analysis 2012 to 2021 and Forecast, 2022 to 2032, By Product
Table 91: MEA Market Size (US$ Million) Analysis 2012 to 2021, By Indication
Table 92: MEA Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Indication
Table 93: MEA Market Size (US$ Million) Analysis 2012 to 2021, By Artery
Table 94: MEA Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Artery
Table 95: MEA Market Size (US$ Million) Analysis 2012 to 2021, By End User
Table 96: MEA Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By End User
Table 97: MEA Market Size (US$ Million) Analysis 2012 to 2021, By Country
Table 98: MEA Market Size (US$ Million) Opportunity Assessment 2022 to 2032, By Country
Figure 01: Global Market Volume (in Thousands) Analysis, 2012 to 2021
Figure 02: Global Market Volume (in Thousands) & Y-o-Y Growth (%) Forecast, 2022 to 2032
Figure 03: Global Average Pricing Analysis Benchmark US$ per unit (2021)
Figure 04: Global Market Value Analysis (US$ Mn), 2012 to 2021
Figure 05: Global Market Value Forecast (US$ Mn), 2022 to 2032
Figure 06: Global Market Absolute $ Opportunity, 2021 to 2032
Figure 07: Global Market Share Analysis (%), By Product, 2022 & 2032
Figure 08: Global Market Y-o-Y Analysis (%), By Product, 2022 to 2032
Figure 09: Global Market Attractiveness Analysis By Product, 2022 to 2032
Figure 10: Global Market Share Analysis (%), By Indication, 2022 & 2032
Figure 11: Global Market Y-o-Y Analysis (%), By Indication, 2022 to 2032
Figure 12: Global Market Attractiveness Analysis By Indication, 2022 to 2032
Figure 13: Global Market Share Analysis (%), By Artery, 2022 & 2032
Figure 14: Global Market Y-o-Y Analysis (%), By Artery, 2022 to 2032
Figure 15: Global Market Attractiveness Analysis By Artery, 2022 to 2032
Figure 16: Global Market Share Analysis (%), By End User, 2022 & 2032
Figure 17: Global Market Y-o-Y Analysis (%), By End User, 2022 to 2032
Figure 18: Global Market Attractiveness Analysis By End User, 2022 to 2032
Figure 19: Global Market Share Analysis (%), By Region, 2022 & 2032
Figure 20: Global Market Y-o-Y Analysis (%), By Region, 2022 to 2032
Figure 21: Global Market Attractiveness Analysis By Region, 2022 to 2032
Figure 22: North America Market Value Share By Product 2022 (E)
Figure 23: North America Market Value Share By End User 2022 (E)
Figure 24: North America Market Value Share By Artery 2022 (E)
Figure 25: North America Market Value Share By End User 2022 (E)
Figure 26: North America Market Value Share By Country 2022 (E)
Figure 27: North America Market Attractiveness Analysis By Product, 2022 to 2032
Figure 28: North America Market Attractiveness Analysis By Indication, 2022 to 2032
Figure 29: North America Market Attractiveness Analysis by Artery, 2022 to 2032
Figure 30: North America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 31: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 32: USA Market Value Proportion Analysis, 2021
Figure 33: USA Market Share Analysis (%), By Product, 2021 & 2032
Figure 34: USA Market Share Analysis (%), By Indication, 2021 & 2032
Figure 35: USA Market Share Analysis (%), By Artery, 2021 & 2032
Figure 36: USA Market Share Analysis (%), By End User, 2021 & 2032
Figure 37: Canada Market Value Proportion Analysis, 2021
Figure 38: Canada Market Share Analysis (%), By Product, 2021 & 2032
Figure 39: Canada Market Share Analysis (%), By Indication, 2021 & 2032
Figure 40: Canada Market Share Analysis (%), By Artery, 2021 & 2032
Figure 41: Canada Market Share Analysis (%), By End User, 2021 & 2032
Figure 42: Latin America Market Value Share By Product 2022 (E)
Figure 43: Latin America Market Value Share By End User 2022 (E)
Figure 44: Latin America Market Value Share By Artery 2022 (E)
Figure 45: Latin America Market Value Share By End User 2022 (E)
Figure 46: Latin America Market Value Share By Country 2022 (E)
Figure 47: Latin America Market Attractiveness Analysis By Product, 2022 to 2032
Figure 48: Latin America Market Attractiveness Analysis By Indication, 2022 to 2032
Figure 49: Latin America Market Attractiveness Analysis by Artery, 2022 to 2032
Figure 50: Latin America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 51: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 52: Brazil Market Value Proportion Analysis, 2021
Figure 53: Brazil Market Share Analysis (%), By Product, 2021 & 2032
Figure 54: Brazil Market Share Analysis (%), By Indication, 2021 & 2032
Figure 55: Brazil Market Share Analysis (%), By Artery, 2021 & 2032
Figure 56: Brazil Market Share Analysis (%), By End User, 2021 & 2032
Figure 57: Mexico Market Value Proportion Analysis, 2021
Figure 58: Mexico Market Share Analysis (%), By Product, 2021 & 2032
Figure 59: Mexico Market Share Analysis (%), By Indication, 2021 & 2032
Figure 60: Mexico Market Share Analysis (%), By Artery, 2021 & 2032
Figure 61: Mexico Market Share Analysis (%), By End User, 2021 & 2032
Figure 62: Argentina Market Value Proportion Analysis, 2021
Figure 63: Argentina Market Share Analysis (%), By Product, 2021 & 2032
Figure 64: Argentina Market Share Analysis (%), By Indication, 2021 & 2032
Figure 65: Argentina Market Share Analysis (%), By Artery, 2021 & 2032
Figure 66: Argentina Market Share Analysis (%), By End User, 2021 & 2032
Figure 67: Europe Market Value Share By Product 2022 (E)
Figure 68: Europe Market Value Share By End User 2022 (E)
Figure 69: Europe Market Value Share By Artery 2022 (E)
Figure 70: Europe Market Value Share By End User 2022 (E)
Figure 71: Europe Market Value Share By Country 2022 (E)
Figure 72: Europe Market Attractiveness Analysis By Product, 2022 to 2032
Figure 73: Europe Market Attractiveness Analysis By Indication, 2022 to 2032
Figure 74: Europe Market Attractiveness Analysis by Artery, 2022 to 2032
Figure 75: Europe Market Attractiveness Analysis by End User, 2022 to 2032
Figure 76: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 77: Germany Market Value Proportion Analysis, 2021
Figure 78: Germany Market Share Analysis (%), By Product, 2021 & 2032
Figure 79: Germany Market Share Analysis (%), By Indication, 2021 & 2032
Figure 80: Germany Market Share Analysis (%), By Artery, 2021 & 2032
Figure 81: Germany Market Share Analysis (%), By End User, 2021 & 2032
Figure 82: Italy Market Value Proportion Analysis, 2021
Figure 83: Italy Market Share Analysis (%), By Product, 2021 & 2032
Figure 84: Italy Market Share Analysis (%), By Indication, 2021 & 2032
Figure 85: Italy Market Share Analysis (%), By Artery, 2021 & 2032
Figure 86: Italy Market Share Analysis (%), By End User, 2021 & 2032
Figure 87: France Market Value Proportion Analysis, 2021
Figure 88: France Market Share Analysis (%), By Product, 2021 & 2032
Figure 89: France Market Share Analysis (%), By Indication, 2021 & 2032
Figure 90: France Market Share Analysis (%), By Artery, 2021 & 2032
Figure 91: France Market Share Analysis (%), By End User, 2021 & 2032
Figure 92: United Kingdom Market Value Proportion Analysis, 2021
Figure 93: United Kingdom Market Share Analysis (%), By Product, 2021 & 2032
Figure 94: United Kingdom Market Share Analysis (%), By Indication, 2021 & 2032
Figure 95: United Kingdom Market Share Analysis (%), By Artery, 2021 & 2032
Figure 96: United Kingdom Market Share Analysis (%), By End User, 2021 & 2032
Figure 97: Spain Market Value Proportion Analysis, 2021
Figure 98: Spain Market Share Analysis (%), By Product, 2021 & 2032
Figure 99: Spain Market Share Analysis (%), By Indication, 2021 & 2032
Figure 100: Spain Market Share Analysis (%), By Artery, 2021 & 2032
Figure 101: Spain Market Share Analysis (%), By End User, 2021 & 2032
Figure 102: BENELLUX Market Value Proportion Analysis, 2021
Figure 103: BENELLUX Market Share Analysis (%), By Product, 2021 & 2032
Figure 104: BENELLUX Market Share Analysis (%), By Indication, 2021 & 2032
Figure 105: BENELLUX Market Share Analysis (%), By Artery, 2021 & 2032
Figure 106: BENELLUX Market Share Analysis (%), By End User, 2021 & 2032
Figure 107: Russia Market Value Proportion Analysis, 2021
Figure 108: Russia Market Share Analysis (%), By Product, 2021 & 2032
Figure 109: Russia Market Share Analysis (%), By Indication, 2021 & 2032
Figure 110: Russia Market Share Analysis (%), By Artery, 2021 & 2032
Figure 111: Russia Market Share Analysis (%), By End User, 2021 & 2032
Figure 112: Nordic Countries Market Value Proportion Analysis, 2021
Figure 113: Nordic Countries Market Share Analysis (%), By Product, 2021 & 2032
Figure 114: Nordic Countries Market Share Analysis (%), By Indication, 2021 & 2032
Figure 115: Nordic Countries Market Share Analysis (%), By Artery, 2021 & 2032
Figure 116: Nordic Countries Market Share Analysis (%), By End User, 2021 & 2032
Figure 117: East Asia Market Value Share By Product 2022 (E)
Figure 118: East Asia Market Value Share By End User 2022 (E)
Figure 119: East Asia Market Value Share By Artery 2022 (E)
Figure 120: East Asia Market Value Share By End User 2022 (E)
Figure 121: East Asia Market Value Share By Country 2022 (E)
Figure 122: East Asia Market Attractiveness Analysis By Product, 2022 to 2032
Figure 123: East Asia Market Attractiveness Analysis By Indication, 2022 to 2032
Figure 124: East Asia Market Attractiveness Analysis by Artery, 2022 to 2032
Figure 125: East Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 126: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 127: China Market Value Proportion Analysis, 2021
Figure 128: China Market Share Analysis (%), By Product, 2021 & 2032
Figure 129: China Market Share Analysis (%), By Indication, 2021 & 2032
Figure 130: China Market Share Analysis (%), By Artery, 2021 & 2032
Figure 131: China. Market Share Analysis (%), By End User, 2021 & 2032
Figure 132: Japan Market Value Proportion Analysis, 2021
Figure 133: Japan Market Share Analysis (%), By Product, 2021 & 2032
Figure 134: Japan Market Share Analysis (%), By Indication, 2021 & 2032
Figure 135: Japan Market Share Analysis (%), By Artery, 2021 & 2032
Figure 136: Japan Market Share Analysis (%), By End User, 2021 & 2032
Figure 137: South Korea Market Value Proportion Analysis, 2021
Figure 138: South Korea Market Share Analysis (%), By Product, 2021 & 2032
Figure 139: South Korea Market Share Analysis (%), By Indication, 2021 & 2032
Figure 140: South Korea Market Share Analysis (%), By Artery, 2021 & 2032
Figure 141: South Korea. Market Share Analysis (%), By End User, 2021 & 2032
Figure 142: South Asia Market Value Share By Product 2022 (E)
Figure 143: South Asia Market Value Share By End User 2022 (E)
Figure 144: South Asia Market Value Share By Artery 2022 (E)
Figure 145: South Asia Market Value Share By End User 2022 (E)
Figure 146: South Asia Market Value Share By Country 2022 (E)
Figure 147: South Asia Market Attractiveness Analysis By Product, 2022 to 2032
Figure 148: South Asia Market Attractiveness Analysis By Indication, 2022 to 2032
Figure 149: South Asia Market Attractiveness Analysis by Artery, 2022 to 2032
Figure 150: South Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 151: South Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 152: India Market Value Proportion Analysis, 2021
Figure 153: India Market Share Analysis (%), By Product, 2021 & 2032
Figure 154: India Market Share Analysis (%), By Indication, 2021 & 2032
Figure 155: India Market Share Analysis (%), By Artery, 2021 & 2032
Figure 156: India Market Share Analysis (%), By End User, 2021 & 2032
Figure 157: Indonesia Market Value Proportion Analysis, 2021
Figure 158: Indonesia Market Share Analysis (%), By Product, 2021 & 2032
Figure 159: Indonesia Market Share Analysis (%), By Indication, 2021 & 2032
Figure 160: Indonesia Market Share Analysis (%), By Artery, 2021 & 2032
Figure 161: Indonesia Market Share Analysis (%), By End User, 2021 & 2032
Figure 162: Malaysia Market Value Proportion Analysis, 2021
Figure 163: Malaysia Market Share Analysis (%), By Product, 2021 & 2032
Figure 164: Malaysia Market Share Analysis (%), By Indication, 2021 & 2032
Figure 165: Malaysia Market Share Analysis (%), By Artery, 2021 & 2032
Figure 166: Malaysia Market Share Analysis (%), By End User, 2021 & 2032
Figure 167: Thailand Market Value Proportion Analysis, 2021
Figure 168: Thailand Market Share Analysis (%), By Product, 2021 & 2032
Figure 169: Thailand Market Share Analysis (%), By Indication, 2021 & 2032
Figure 170: Thailand Market Share Analysis (%), By Artery, 2021 & 2032
Figure 171: Thailand Market Share Analysis (%), By End User, 2021 & 2032
Figure 172: Oceania Market Value Share By Product 2022 (E)
Figure 173: Oceania Market Value Share By End User 2022 (E)
Figure 174: Oceania Market Value Share By Artery 2022 (E)
Figure 175: Oceania Market Value Share By End User 2022 (E)
Figure 176: Oceania Market Value Share By Country 2022 (E)
Figure 177: Oceania Market Attractiveness Analysis By Product, 2022 to 2032
Figure 178: Oceania Market Attractiveness Analysis By Indication, 2022 to 2032
Figure 179: Oceania Market Attractiveness Analysis by Artery, 2022 to 2032
Figure 180: Oceania Market Attractiveness Analysis by End User, 2022 to 2032
Figure 181: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 182: Australia Market Value Proportion Analysis, 2021
Figure 183: Australia Market Share Analysis (%), By Product, 2021 & 2032
Figure 184: Australia Market Share Analysis (%), By Indication, 2021 & 2032
Figure 185: Australia Market Share Analysis (%), By Artery, 2021 & 2032
Figure 186: Australia Market Share Analysis (%), By End User, 2021 & 2032
Figure 187: New Zealand Market Value Proportion Analysis, 2021
Figure 188: New Zealand Market Share Analysis (%), By Product, 2021 & 2032
Figure 189: New Zealand Market Share Analysis (%), By Indication, 2021 & 2032
Figure 190: New Zealand Market Share Analysis (%), By Artery, 2021 & 2032
Figure 191: New Zealand Market Share Analysis (%), By End User, 2021 & 2032
Figure 192: MEA Market Value Share By Product 2022 (E)
Figure 193: MEA Market Value Share By End User 2022 (E)
Figure 194: MEA Market Value Share By Artery 2022 (E)
Figure 195: MEA Market Value Share By End User 2022 (E)
Figure 196: MEA Market Value Share By Country 2022 (E)
Figure 197: MEA Market Attractiveness Analysis By Product, 2022 to 2032
Figure 198: MEA Market Attractiveness Analysis By Indication, 2022 to 2032
Figure 199: MEA Market Attractiveness Analysis by Artery, 2022 to 2032
Figure 200: MEA Market Attractiveness Analysis by End User, 2022 to 2032
Figure 201: MEA Market Attractiveness Analysis by Country, 2022 to 2032
Figure 202: GCC Countries Market Value Proportion Analysis, 2021
Figure 203: GCC Countries Market Share Analysis (%), By Product, 2021 & 2032
Figure 204: GCC Countries Peripheral Vascular Devices Market Share Analysis (%), By Indication, 2021 & 2032
Figure 205: GCC Countries Peripheral Vascular Devices Market Share Analysis (%), By Artery, 2021 & 2032
Figure 206: GCC Countries Market Share Analysis (%), By End User, 2021 & 2032
Figure 207: Turkey Market Value Proportion Analysis, 2021
Figure 208: Turkey Market Share Analysis (%), By Product, 2021 & 2032
Figure 209: Turkey Market Share Analysis (%), By Indication, 2021 & 2032
Figure 210: Turkey Market Share Analysis (%), By Artery, 2021 & 2032
Figure 211: Turkey Market Share Analysis (%), By End User, 2021 & 2032
Figure 212: Israel Market Value Proportion Analysis, 2021
Figure 213: Israel Market Share Analysis (%), By Product, 2021 & 2032
Figure 214: Israel Market Share Analysis (%), By Indication, 2021 & 2032
Figure 215: Israel Market Share Analysis (%), By Artery, 2021 & 2032
Figure 216: Israel Market Share Analysis (%), By End User, 2021 & 2032
Figure 217: North Africa Market Value Proportion Analysis, 2021
Figure 218: North Africa Market Share Analysis (%), By Product, 2021 & 2032
Figure 219: North Africa Market Share Analysis (%), By Indication, 2021 & 2032
Figure 220: North Africa Market Share Analysis (%), By Artery, 2021 & 2032
Figure 221: North Africa Market Share Analysis (%), By End User, 2021 & 2032
Figure 222: South Africa Market Value Proportion Analysis, 2021
Figure 223: South Africa Market Share Analysis (%), By Product, 2021 & 2032
Figure 224: South Africa Market Share Analysis (%), By Indication, 2021 & 2032
Figure 225: South Africa Market Share Analysis (%), By Artery, 2021 & 2032
Figure 226: South Africa Market Share Analysis (%), By End User, 2021 & 2032
The global peripheral vascular devices market is worth USD 4.5 Billion in 2021 and is set to expand 1.9X over the next ten years.
The peripheral vascular devices market is expected to reach USD 8.9 Billion by the end of 2032, with sales revenue expected to register 6.6% CAGR.
The growing burden of cardiovascular diseases, rising awareness regarding cardiovascular procedures, and the adoption of minimally invasive surgical techniques are some of the key trends in this market.
The USA, China, Germany, the United Kingdom, and India are expected to drive demand for the peripheral vascular devices industry.
Demand for peripheral vascular devices in South Asia is expected to register a 7.1% CAGR over the next ten years.
North America is one of the key markets for peripheral vascular devices, with the USA accounting for about 94.5% of the North American peripheral vascular devices market in the year 2021.
Demand for peripheral vascular devices in Europe is expected to register a 6.2% CAGR over the next ten years.
The USA, China, and Germany are the key producers of peripheral vascular devices.
Demand for peripheral vascular devices in the Middle East and Africa(MEA) is expected to register a 5.7% CAGR over the next ten years.
Abbott Laboratories, Boston Scientific Corporation, Cook Medical Inc., MicroPort Scientific Corporation (Endovastec™), Medtronic Plc., Cardinal Health, Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Becton, Dickinson and Company, W. L. Gore & Associates Inc., Getinge AB, Terumo Corp, Kyoto Medical Planning Co Ltd, iVascular S.L.U, AMG International GmbH, ENDOCOR GmbH, Meril Life Sciences Pvt. Ltd., Nano Therapeutics Pvt Ltd, Koninklijke Philips N.V., and REVA Medical, are some of the key pl
Explore Similar Insights
Peripheral Vascular Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
